MY ACCOUNT
Complementary
Showing 1–12 of 27 results
A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression
Nonsteroidal anti-inflammatory drugs (NSAIDs) and antioxidative treatments have shown antidepressant potential as adjunct treatments. Read this article to learn if adjunctive treatment with the antioxidative agent N-acetylcysteine, the NSAID aspirin, or both helped reduce depressive symptoms in patients with bipolar depression.
A Supervised Exercise Intervention for Youth at Risk for Psychosis: An Open-Label Pilot Study
Exercise has been shown to curb some psychiatric symptoms, but can it prevent them? In this small study of young adults at ultrahigh risk for psychosis, researchers showed how exercise affects clinical, social, and cognitive domains as well as changes to brain function regions impacted by the development of psychosis.
Use of Omega-3 Polyunsaturated Fatty Acids as Augmentation Therapy in Treatment-Resistant Schizophrenia
Fish oil supplements containing omega-3 fatty acid are among the most commonly used nutraceuticals. Although their role as augmentation therapy has been studied in schizophrenia, their benefits are unclear in treatment-resistant cases. Read this case report of a treatment-resistant patient with schizophrenia who achieved remission with omega-3 fatty acid supplementation.
Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Bipolar Disorder: A Review of Biomarker and Treatment Studies
Considering omega-3 and omega-6 fatty acids to supplement bipolar treatment? Read this review article for the latest evidence on this promising treatment strategy.
A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications
Too much of a good thing? As of June 2016, marijuana was legal for medical use in 25 states in the US. Learn what the authors discovered during their systematic review of the quality of evidence, and see whether medical marijuana's risks and benefits make it a good thing for psychiatric indications.
Mania Induced by Garcinia cambogia: A Case Series
The weight loss supplement Garcinia cambogia is considered to be serotonergic, yet literature about its psychiatric effects is limited. The authors of this Letter to the Editor report the cases of 3 stable, euthymic adults whose mania emerged when they began taking Garcinia cambogia. In all 3 cases, recovery included cessation of Garcinia cambogia and usual clinical treatment.
Toxic Effects of Psychotropics Related to Possible P450 Enzyme Inhibition by Kava: Report of 2 Cases
Two cases of patients seen on the psychiatric emergency and consult service who developed severe side effects from psychotropic medications in the context of kava use are presented. In both cases, kava use may have affected the metabolism of the psychotropic medications, leading to serious side effects.Â
Effectiveness of Yoga Therapy as a Complementary Treatment for Major Psychiatric Disorders: A Meta-Analysis
The authors of this study examined the efficacy of yoga therapy as a complementary treatment for psychiatric disorders such as schizophrenia, depression, anxiety, and posttraumatic stress disorder.
